This has been applied by researchers who reported how the polyethylene glycol-conjugated hemoglobin (PEG-Hb) treatment prevented HIF-1 from increasing and hence reducing the VEGF expression, which is the downstream protein that is strongly linked to tumor angiogenesis. Here, VEGFA is linked to neoplasm.